Macrophage polarization in gynecologic malignancies: key signaling pathways and clinical perspectives
-
By
-
Qian He
-
Yali Chen
-
June 30, 2026
-
Clinical Scorecard: Macrophage Polarization in Female Cancers: Essential Signaling Pathways and Clinical Implications
At a Glance
| Category | Detail |
|---|
| Condition | Gynecological malignancies |
| Key Mechanisms | Tumor-associated macrophages (TAMs) polarization and signaling pathways |
| Target Population | Women with ovarian cancer, cervical cancer, and endometrial cancer |
| Care Setting | Clinical translation of immunotherapies targeting TAMs |
Key Highlights
- TAMs play a pivotal role in the tumor microenvironment (TME).
- M1 and M2 macrophage polarization affects tumor growth and immune response.
- Nano-drug delivery systems (NDDSs) are advancing TAM-targeted therapies.
- TAMs account for up to 50% of the cellular composition in some solid tumors.
- Recent studies reveal complexity beyond the M1/M2 macrophage classification.
Guideline-Based Recommendations
Diagnosis
- Identify gynecological malignancies through standard diagnostic procedures.
Management
- Consider immunotherapy approaches that modulate TAMs in treatment plans.
Monitoring & Follow-up
- Monitor TAM polarization and its impact on treatment response.
Risks
- Evaluate the risks associated with immunotherapy targeting TAMs.
Patient & Prescribing Data
Women diagnosed with gynecological cancers.
Immunotherapy targeting TAMs is in early research stages.
Clinical Best Practices
- Utilize scRNA-seq for detailed analysis of TAM subtypes.
- Focus on the modulation of TAM signaling pathways for therapeutic strategies.
- Incorporate NDDSs for targeted delivery in TAM therapies.
Related Resources & Content
